Annual Shareholders Equity
$107.60 M
-$21.12 M-16.41%
December 1, 2023
Summary
- As of February 7, 2025, CLYM annual stockholders equity is $107.60 million, with the most recent change of -$21.12 million (-16.41%) on December 1, 2023.
- During the last 3 years, CLYM annual shareholders equity has risen by +$86.03 million (+398.88%).
- CLYM annual shareholders equity is now -35.65% below its all-time high of $167.20 million, reached on December 1, 2021.
Performance
CLYM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$218.78 M
-$3.50 M-1.58%
September 1, 2024
Summary
- As of February 7, 2025, CLYM quarterly stockholders equity is $218.78 million, with the most recent change of -$3.50 million (-1.58%) on September 1, 2024.
- Over the past year, CLYM quarterly shareholders equity has dropped by -$3.50 million (-1.58%).
- CLYM quarterly shareholders equity is now -1.58% below its all-time high of $222.28 million, reached on June 1, 2024.
Performance
CLYM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CLYM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.4% | -1.6% |
| 3 y3 years | +398.9% | -1.6% |
| 5 y5 years | +422.0% | -1.6% |
CLYM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.6% | at low | -1.6% | +105.7% |
| 5 y | 5-year | -35.6% | +422.0% | -1.6% | +914.4% |
| alltime | all time | -35.6% | +422.0% | -1.6% | +914.4% |
Climb Bio Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $218.78 M(-1.6%) |
| Jun 2024 | - | $222.28 M(+108.9%) |
| Mar 2024 | - | $106.38 M(-1.1%) |
| Dec 2023 | $107.60 M(-16.4%) | $107.60 M(-2.0%) |
| Sep 2023 | - | $109.74 M(-2.5%) |
| Jun 2023 | - | $112.50 M(-3.7%) |
| Mar 2023 | - | $116.86 M(-9.2%) |
| Dec 2022 | $128.72 M | $128.72 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $134.36 M(-5.5%) |
| Jun 2022 | - | $142.24 M(-8.3%) |
| Mar 2022 | - | $155.14 M(-7.2%) |
| Dec 2021 | $167.20 M(+675.2%) | $167.20 M(-5.4%) |
| Sep 2021 | - | $176.66 M(+73.3%) |
| Jun 2021 | - | $101.91 M(+105.4%) |
| Mar 2021 | - | $49.62 M(+130.0%) |
| Dec 2020 | $21.57 M(+4.6%) | $21.57 M |
| Dec 2019 | $20.61 M | - |
FAQ
- What is Climb Bio annual stockholders equity?
- What is the all time high annual shareholders equity for Climb Bio?
- What is Climb Bio annual shareholders equity year-on-year change?
- What is Climb Bio quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Climb Bio?
- What is Climb Bio quarterly shareholders equity year-on-year change?
What is Climb Bio annual stockholders equity?
The current annual shareholders equity of CLYM is $107.60 M
What is the all time high annual shareholders equity for Climb Bio?
Climb Bio all-time high annual stockholders equity is $167.20 M
What is Climb Bio annual shareholders equity year-on-year change?
Over the past year, CLYM annual stockholders equity has changed by -$21.12 M (-16.41%)
What is Climb Bio quarterly stockholders equity?
The current quarterly shareholders equity of CLYM is $218.78 M
What is the all time high quarterly shareholders equity for Climb Bio?
Climb Bio all-time high quarterly stockholders equity is $222.28 M
What is Climb Bio quarterly shareholders equity year-on-year change?
Over the past year, CLYM quarterly stockholders equity has changed by -$3.50 M (-1.58%)